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Chapter

Personalized Digital Phenotype
Score, Healthcare Management
and Intervention Strategies using
Knowledge Enabled Digital Health
Framework for Pediatric Asthma
Utkarshani Jaimini and Amit Sheth

Abstract
Asthma is a personalized, and multi-trigger respiratory condition which requires
continuous monitoring and management of symptoms and medication adherence.
We developed kHealth: Knowledge-enabled Digital Healthcare Framework to
monitor and manage the asthma symptoms, medication adherence, lung function,
daily activity, sleep quality, indoor, and outdoor environmental triggers of pediatric
asthma patients. The kHealth framework collects up to 1852 data points per patient
per day. It is practically impossible for the clinicians, parents, and the patient to
analyze this vast amount of multimodal data collected from the kHealth framework. In this chapter, we describe the personalized scores, clinically relevant asthma
categorization using digital phenotype score, actionable insights, and potential
intervention strategies for better pediatric asthma management.
Keywords: Pediatric patients, Asthma management, Multimodal data,
Personalization, Intervention, Digital phenotype, Actionable information,
Self monitoring, Self management

1. Introduction
Asthma is a multi-trigger disease with or without co-morbities such as obstructive sleep apnea, increase in body mass index (BMI), rhinitis, sinusitis, gastroesophageal reflux disease, psychopathologies etc. [1]. 8.3% of children in United
States suffer from asthma [2]. Pediatric asthma affects the child’s quality of life
with reduced activity, lack of concentration, growing up with missed school days,
emergency room visits, etc. [3].
As per the current clinical practice, the clinician does not get the holistic view of
the asthma patient’s health condition during the clinic visit scheduled once in every
one to two months for severe persistent and once in six months for mild persistent
asthma patient [4]. However, with the advent of Internet of Things (IoTs) sensors
and mobile applications for collecting Patient Generated Health Data (PGHD) it
has become convenient for patients (parents in the case of children below age 12)
to log their daily symptoms, medication intake, and daily activity. The multi-modal
1
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PGHD is big data which suffers from challenges of velocity, volume, and variety [5].
The data is collected at different intervals for each sensor, is of different variety and
volume. It is challenging to integrate this overwhelming data for analysis. It is impossible for the clinicians alone to analyze this data coming in with different velocity,
variety, and volume along with their existing duties. It is challenging and practically
impossible for the clinicians and the patients to generate actionable insights from this
vast amount of data due to lack of time, resources, and data analysis skills [6].
In this chapter, we introduce a knowledge enabled healthcare framework,
kHealth, which is being used by the pediatric asthma patients for self monitoring
and by the clinicians to derive real time insights into patient’s healthcare protocol.
The technologies like kHealth are extremely useful especially during a pandemic
when the in-person patient visits shifts to telemedicine appointments [7]. The clinicians can use kHealth framework during the telemedicine appointment to visually
explores the PGHD along with the EMRs to better understand the patient’s disease
prognosis and suggest diagnoses. Also, a patient can use the kHealth framework to
continuously monitor, appraise, and manage her chronic disease [8]. A detailed scenario for a pediatric asthma patient is given in [8, 9] [See Multimedia Appendix A].
The data collected from the kHealth framework is used to simulate Personalized
Scores, and Digital Phenotype Score (DPS) which is a clinical equivalent for the Asthma
Control Test (ACT) score. The DPS is used to categorize the asthma patients into their
asthma control levels and recommend intervention strategies to the clinicians.
The chapter is divided into seven sections, Section 1 is introduction, Section 2
provides a brief overview of the kHealth framework and it’s components, Section 3
explains the study methods, study design, and study protocol, Section 4 discusses the
personalized scores followed by Section 5 on Digital Phenotype Score, Section 6 discusses actionable insights and causal intervention, and Section 7 concludes the chapter.

2. kHealth: knowledge-enabled healthcare
A knowledge-enabled healthcare framework, kHealth (Figure 1, Multimedia
Appendix B), is a personalized framework for self monitoring of patient’s symptoms, medication adherence, lung function, activity, etc. for pediatric asthma
patients. The framework utilizes the existing medical knowledge along with
the PGHD to assist the child, parent, and the clinician in better monitoring and

Figure 1.
kHealth architecture.
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management of asthma. It provides an alternative to the traditional episodic
clinician-centric health care by supporting real-time monitoring of a child’s health
condition. kHealth gathers empirical evidences to analyze and monitor disease progression and help in asthma management. It is a step towards exploring issues such
as: What is the asthma control level of the child?, What is the medication compliance of the child?, What are the possible triggers for the child’s asthma symptoms?,
Can we understand the causal relationship between symptoms and possible triggers
or factors responsible for the symptoms?, Can we predict asthma attacks based
on the past data collected from the child?, etc. The kHealth framework consists of
kHealth kit, kHealth cloud, and kHealth dashboard (described below).
2.1 kHealth kit
The kHealth kit consists of an android application (kHealth application) and a set
of sensors (Foobot, Fitbit, and a Microlife Peak Flow Meter). Sections below provide a
description of all the sensors and the type of data collected from them. kHealth framework uses the active and passive sensing techniques for data collection. Active sensing
refers to the data collection where the child (or the parent) has to actively interact with
the technology (e.g., answering questions in the kHealth application) [10]. Passive
sensing refers to the data collected without active human interaction with the technology (e.g., Wearing Fitbit which automatically collects activity and sleep data) [10].
2.1.1 kHealth application
The kHealth application is built using the widely used Android platform. The
application is designed in consultation with the clinician, tested with patients, and
iteratively refined before reaching the current version used in the study [11]. The
application asks questions similar to the ACT questionnaire (Table 1). The application captures symptoms, medication intake, and activity limitation because of
asthma symptoms and nighttime awakenings using a questionnaire that the child
is expected to answer twice a day. The application is personalized for every child,
kHealth application questions

Multiple-choice options

Are you currently experiencing any of the
asthma-related symptoms below?

Cough, wheeze, chest tightness, hard and fast breathing,
nose opens wide, cannot talk in full sentences, others

How many times did you take albuterol inhaler
today because of asthma symptoms?

1, 2, 3, 4, 5, 6+

Have you had a wheeze, chest tightness, or
asthma-related cough today?

Yes, No

How much did asthma or asthma symptoms
limit your activity today?

None, a little, most of the day, at least half of the day

Did you take albuterol last night because of a
cough or wheeze?

Yes, No

Did you wake up with a cough or wheeze last
night?

Yes, No

Rescue medication question. For example, did
you take albuterol today?

Yes, No

Controller medication question. For example,
did you take Dulera today?

Yes, No

Table 1.
kHealth application questionnaire.
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such as the medication (rescue and controller) information for every child is taken
from the Electronic Medical Records (EMRs), and the medication intake questions
are asked for the prescribed medications only. Table 1 below shows the kHealth
application questionnaire.
2.1.2 Fitbit
Fitbit is a wearable sensor which collects activity signals such daily step count,
distance walked, floor climbed, sedentary minutes, lightly active minutes, fairly
active minutes, very active minutes, and calories burned during the activities. The
sleep signals includes minutes asleep at night, minutes awake, number of time the
child woke up at night (number of awakenings), time spend in bed, minutes of
REM (Rapid Eye Movement) sleep, minutes of light sleep, and minutes of deep
sleep. The child is required to wear the Fitbit provided as part of the kHealth kit
during the day and night.
2.1.3 Foobot
Foobot, is an indoor air quality sensor [12]. It is setup in the child’s room or in
the place in the house where the child spends majority of his/her time indoor. It
connects to the home wifi, and records signal every 5-15 mins. The foobot records
indoor temperature, humidity, carbon dioxide, volatile organic compound (VOC),
and particulate matter 2.5 (PM2.5). The sensor turns red from green (healthy air
quality) as an indicator of bad or unhealthy indoor air quality.
2.1.4 Microlife peak flow meter
Microlife Peak Flow Meter is used to record the child’s lung function measures
such as forced exhaled volume in 1 sec (FEV1) and peak expiratory flow (PEF).
The peak flow meter has in-built memory to save upto 240 readings. Microlife has
a free software available to the user to download their readings from the meter.
The reading is taken by standing/sitting up straight, and blowing hard in the meter
thrice. The device saves the highest of the three readings. As a backup, the child is
also asked to input the reading in the kHealth application.
2.2 kHealth cloud
The data collected from the kHealth kit are synced in real time with Firebase,
a Google cloud storage. Firebase provides active data listening for the client-side,
which offers data persistence over a network failure and resyncs to the cloud when
the network is restored. The kHealth application uses SQLite as the primary data
storage and Firebase as the secondary data storage. Data from Firebase are available
to Kno.e.sis researchers and clinicians for real-time analysis. Firebase provides a set
of real-time database rules and user authentication that allow data access control on
a per-user basis. It is built on the Google Cloud Platform, sharing the same level of
data security [13].
2.3 kHealth Dashboard
kHealth Dashboard (Figure 2, Multimedia Appendix C) is a cloud-based
platform that integrates and visualizes multi-modal PGHD data from the kHealth
kit. kHealth Dashboard visually explores the correlations between the child’s
readings about their asthma symptoms, lung function, medication usage, and
4
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Figure 2.
kHealth dashboard.

environmental data [14] In the Figure 2, the patient in consideration is prescribed
Albuterol, Atrovent, Singulair and Dulera by the clinician, had 24 intakes of rescue
medication (short-acting) during the course of the study, had symptoms of cough,
chest tightness and wheeze, had activity limitations, and had maximum PEF/FEV1
values of 112/0.89 and 98/0.87 in the day and night respectively during the course
of the study. The patient took rescue medications on 10th March when the outdoor
environment condition was: ozone 44 (good), pollen 6 (medium), and particulate
matter 78 (moderate). The next section describes the study procedure such as study
design, study recruitment, etc.

3. Methods
The section describes the kHealth study design and study recruitment process.
3.1 Study design
kHealth is an observational longitudinal study involving collaboration among
researchers from the Artificial Intelligence Institute at the University of South
Carolina, Kno.e.sis—an Ohio Center of Excellence for BioHealth Innovations at
Wright State University, and Dayton Children’s Hospital (DCH), the latter consisting of a clinician and a nurse coordinator. The study was approved by the DCH
institutional review board (IRB). The study uses off the shelf sensors and widely
used technologies. The study comprises of 30 kits which allows parallel participation of up to 30 children at a time. The kHealth framework does not save any patient
identified information such as name, date of birth, etc. The kHealth participant is
given a kHealth ID such as KH001, KH002 to anonymize the data. The information
to anonymize and de-anonymize is stored only at the DCH and is not shared with
the researchers [15]. The information never leave the DCH servers.
3.2 Study recruitment
The study participants were recruited from Dayton Children’s Hospital (DCH)
under the guidance of a pediatric pulmonologist. The participants were children
5
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within the age group of 5-17 years diagnosed with asthma. The study coordinator
approached the parents of the children seeking asthma treatment at the DCH.
The parent, along with the child, consent to participate in the study. The parent
provides consent, and the child assent by signing a consent form to participate in
the study and giving permission to obtain the medical details from the EMRs. The
participant recruitment was random, with asthma diagnoses as the only prerequisite. The type of asthma, such as persistent, non persistent, exercise induced,
and non exercise-induced asthma was not taken into consideration for the study
recruitment. The participant were given an option to participate in either one
month or three month study period. The consented participant were given a brief
demonstration of all the kHealth components. The participants also had access
to a user guide, tutorial video in the application to make it more accessible. The
contact information of the study coordinator, and the kHealth team were saved in
the user guide to reach out in case of any technical difficulties. The technical difficulties were resolved by the kHealth team while keeping the participant identity
anonymized.
The PGHD collected from the pediatric patients using the kHealth framework
is used to generate personalized insights into one’s healthcare protocol. The next
section describes the personalization in chronic diseases like asthma and how does
the PGHD can be used for better disease management, and self appraisal.

4. Personalization
Asthma is a personalized disease. An asthma patient differs from another
patient with respect to their asthma symptoms, possible triggers, medication
adherence, and asthma control levels. The below observation comes from preliminary analysis and anecdotal evidence from the data. For example, Patients
A and B, both in the same asthma control, and severity level category and have
fall pollen allergies. However, Patient A does not show symptoms until the pollen
crosses the threshold 6 (pollen: medium [16]) whereas Patient B starts showing
symptoms as soon as the pollen levels goes beyond 3 (pollen: low-medium [16]).
Personalization in the kHealth framework is able to capture these granularities
(symptoms, medication intake, difficulty sleeping and reduced activity due to
the outdoor environmental conditions) at a given point in time. We also observe
patients in one asthma control level category are more proactive towards their
health and medication adherence resulting into fewer We define personalized
scores such as Symptom Score, Medication (Rescue, Controller) compliance
Scores, Activity Score, etc. to get a real time insight into the patient’s health
condition unlike the irregular ACT administered during the clinic visits. The personalized scores helps in real time categorization of the patient into their asthma
control levels.
4.1 Symptom score
Symptom score for a child is defined by the number of symptoms experienced
by the child during the course of deployment period. The symptom severity (Chest
Tightness being more severe than wheeze and cough, etc) is ignored for the symptom score estimation.
SS =

6

Total symptoms experienced by the child
Study Period

(1)
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4.2 Activity score
Activity Score of a child is the number of days the child had restricted activity
during the study duration. The kHealth application asks a multiple-choice question:
How much did asthma symptoms limit your activity today? with four options: none,
a little, half of the day, and most of the day. The options are weighted on a scale of
0-3, respectively.
AcS =

Number of days of activity restriction ( weighted option )
Study Period

(2)

4.3 Awakening score
The Awakening Score (AwS) is the measure of number of nights the child woke
up because of asthma symptoms during the study period. The kHealth application asks a multiple-choice question: Did you wake up with wheeze, cough, or any
asthma-related symptoms?
AwS =

Number of days child woke up due to asthma
Study Period

(3)

4.4 Rescue compliance score
The kHealth application collects data on the intake of the rescue medication
(short-acting bronchodilators) by asking questions such as Did you take albuterol
today? Rescue Compliance Score (RCS) is defined as the number of times the child
took the rescue medication during the study period. The rescue medication is taken
to mitigate or prevent the symptoms.
RCS =

Total Resuce medication intake by the child
Study Period

(4)

4.5 Controller compliance score
The kHealth application asks questions (eg, Did you take Dulera today?) about
the intake of the controller medication (long-term control medication). An asthmatic patient is prescribed a controller medication, which is supposed to take at
least once a day depending on the asthma control levels. The Controller Compliance
Score (CCS) is defined as the fraction of the number of days the child took the
controller medication during the study period.
CCS =

Total Controller medication intake by the child
Study Period

(5)

The threshold for Controller Compliance Score is defined as Highly Compliant
for score greater than and equal to 0.70, Well Compliant for score greater than and
equal to 0.30 and less than 0.70, and Poorly Compliant for score less than 0.30.
Let us take an example scenario to better understand the personalized scores and
generate actionable insights into their asthma management. Alice is ten yrs. old and
7
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clinically (using the ACT score) categorized into Not Well Controlled asthma control level. She and her parents agreed to participate in the one month kHealth study
period. According to the data collected using the kHealth framework, Alice had
ten incidents of cough, ten incidents of wheeze, five chest tightness, no incidents
of hard and fast breathing, and no incidents of cannot talk in full sentences. She
woke up during the night due to asthma symptoms on ten nights and had asthma
symptom related activity limitation for five days. She had her controller medication
for twenty days and had five rescue medication during her study period. Alice had
a Symptom Score of 0.83 (=25/30; 10 cough +10 wheeze +5 chest tightness = 25
symptoms), Awakening Score of 0.33 (=10/33), Activity Score of 0.16 (=5/30),
Rescue Compliance Score of 0.16 (=5/30), and Controller Compliance Score of 0.66
(=20/30). Alice is Well Compliant for her controller medications. The next section
utilizes the above personalized scores for real time categorization of the child into
their asthma control levels.

5. Digital phenotype score: Asthma categorization
The child (or the parent) is given an Asthma Control Test (ACT) at the regular
checkup appointment. The ACT asks questions about the asthma symptoms,
school days missed, night time awakenings, inhaler intakes etc. in the past four
weeks. The child is categorized into one of the three asthma control levels of Well
Controlled, Not Well Controlled, and Very Poorly Controlled asthma based on the
scores obtained in the test. The ACT is used to analyze the asthma management
of the child in between the visits, and also as a measure of Does the therapy helps
the child’s asthma management?, or Is there a need for intervention and change in
therapy/treatment protocol? The ACT is administered during the infrequent clinic
visit and asks questions about past four weeks, it is highly unlikely the child or the
parent will remember all the relevant asthma episodes which leads to incorrect
asthma control level classification [17, 18].
Digital Phenotype Score (DPS) defined using the kHealth data and National
Heart, Lung, and Blood Institute (NHLBI) guidelines to categorize the child into
their asthma control level overcomes the limitations of the ACT scores [19–22].
The child/parent and the clinician do not have to wait for the clinic visits to get
an analysis of the current asthma management of the child. The clinician can use
the DPS for early and timely intervention to recognize any barriers to the current
therapy. The DPS is a quantified measure of the symptom score, activity score,
awakening score, and rescue compliance score. The DPS of greater than and
equal to one is classified as Very Poorly Controlled asthma, greater than equal to
0.28 and less than one is classified as Not Well Controlled asthma, and less than
0.28 is classified as Well Controlled asthma. In the case of Alice, the DPS is 1.48
(=0.83 + 0.16 + 0.33 + 0.16). According to the thresholds defined her asthma is classified as Very Poorly Controlled.

6. Causal intervention and actionable insights
The Personalized scores along with Digital Phenotype Score related categorization can be used to generate actionable insights into a patient’s healthcare protocol
[21, 23]. These insights in future can also be used by the clinician to design a perfect
intervention strategies/policies (Figure 3) for better health outcome and improving
the quality of life of the patient [24, 25]. Let us take an example scenario, A child
categorized as having Very Poorly Controlled asthma using the DPS, suffering with
8

Personalized Digital Phenotype Score, Healthcare Management and Intervention Strategies…
DOI: http://dx.doi.org/10.5772/intechopen.97430

Figure 3.
Root cause analysis techniques can be used to access the path specific policy update for intervention strategies.

a high symptom score and Highly Compliant for the controller medication. The CCS
and the DPS sheds light on an important aspect of the child’s asthma management
that although the child is highly compliant towards the controller medication but
still suffers from high symptom score. This is an opportunity for the clinician to
intervene with either increasing the medication dosage, or change or add a medication, and identify the environment triggers for mitigation. On the other hand a
child with Very Poorly Controlled asthma and poorly compliant with the controller
medication is in the worst health condition and requires immediate attention from
the clinician and support from the parent/caregiver. The intervention strategy
would be to identify the barriers to medication adherence and suggest mitigation/
alternative efforts. A child with well controlled asthma and highly compliant
with the medication is a use case when the child/parent are proactive towards the
asthma management. In this scenario the clinician can choose to intervene with
either maintaining the therapy or considering changing the medication or lowering
the dosage.
In the case of Alice, she is well compliant with her controller medication and
as per the DPS has very poorly controlled asthma. The clinician can intervene in
her asthma management protocol with either increasing the medication dosage
or adding a new medication since her current medications are unable to control
her asthma, and also provide appropriate preventive suggestions to reduce future
asthma exacerbation.

7. Conclusions
The digital healthcare technologies such as IoTs, self-reporting applications,
wearables can be used to improve the quality of life of the pediatric asthma patients.
The kHealth framework has moved the current healthcare approach from cliniciancentric to patient-centric. The child/parent feels empowered to take control of their
health management. The clinician can include the framework like kHealth in their
current protocol which is especially useful during the pandemic when the care
has shifted from in-person clinic visit to tele-medicine appointment. The asthma
patients are prescribed Longacting combination inhalers, Long-acting inhaled steroids or Oral Steroids depending on how controlled is a patient’s asthma condition.
The long term use of steroids leads to a growth suppression, adrenal gland suppression, osteoporosis, increase a risk of high blood pressure, heart attack, increase in
appetite leading to weight gain and eventually increase in body mass index [26].
The early and timely intervention strategies discussed can be used to avoid overuse
of the steroid medications, and can eliminate the vicious cycle of asthma affecting
obesity or obesity affects asthma.
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